TGF-β: Its role in the differentiation and function of T regulatory and effector cells

The cytokine transforming growth factor-β (TGF-β) plays an important role in the maintenance of T cell homeostasis, immune tolerance to self-antigens, and T cell differentiation during immune responses. TGF-β has pleiotropic effects on adaptive immune responses, especially on the differentiation of T helper and T regulatory cell populations, which depends on the T cell differentiation status and the stimulation conditions. This review provides an update about the roles of TGF-β in T cell responses, especially in the regulation of Treg development and biological features under steady state and inflammation. We also discuss the additional roles that TGF-β plays in the development and function of other T helper cells, such as Th1, Th2, Th9, Th17, and Th22 cells during inflammation.

PDF

___

Ambros (2004). The functions of animal microRNAs. Nature: 431: 350-355.
Andoh A, Zhang Z, Inatomi O, Fujino S, Deguchi Y, Araki Y, Tsujikawa T, Kitoh K, Kim-Mitsuyama S, Takayanagi A et al. (2005). Interleukin-22, a member of the IL-10 subfamily, induces inflammatory responses in colonic subepithelial myofibroblasts. Gastroenterology 129: 969-984.
Ansel KM, Djuretic I, Tanasa B, Rao A (2006). Regulation of Th2 differentiation and Il4 locus accessibility. Annu Rev Immunol 24: 607-656.
Awasthi A, Carrier Y, Peron JP, Bettelli E, Kamanaka M, Flavell RA, Kuchroo VK, Oukka M, Weiner HL (2007). A dominant function for interleukin 27 in generating interleukin 10-producing antiinflammatory T cells. Nat Immunol 8: 1380-1389.
Bartel DP (2004). MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 16: 281-297.
Baumjohann D, Ansel KM (2013). MicroRNA-mediated regulation of T helper cell differentiation and plasticity. Nat Rev Immunol 13: 666-678.
Benson MJ, Pino-Lagos K, Rosemblatt M, Noelle RJ (2007). Alltrans retinoic acid mediates enhanced T reg cell growth, differentiation, and gut homing in the face of high levels of costimulation. J Exp Med 204: 1765-1774.
Bettelli E, Carrier Y, Gao W, Korn T, Strom TB, Oukka M, Weiner HL, Kuchroo VK (2006). Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature 441: 235-238.
Bluestone JA, Abbas AK (2003). Natural versus adaptive regulatory T cells. Nat Rev Immunol 3: 253-257.
Brunkow ME, Jeffery EW, Hjerrild KA, Paeper B, Clark LB, Yasayko SA, Wilkinson JE, Galas D, Ziegler SF, Ramsdell F (2001). Disruption of a new forkhead/winged-helix protein, scurfin, results in the fatal lymphoproliferative disorder of the scurfy mouse. Nat Genet 27: 68-73.
Burchill MA, Yang J, Vogtenhuber C, Blazar BR, Farrar MA (2007). IL-2 receptor beta-dependent STAT5 activation is required for the development of Foxp3+ regulatory T cells. J Immunol 178: 280-290.
Chang HC, Sehra S, Goswami R, Yao W, Yu Q, Stritesky GL, Jabeen R, McKinley C, Ahyi AN, Han L et al. (2010). The transcription factor PU.1 is required for the development of IL-9-producing T cells and allergic inflammation. Nat Immunol 11: 527-534.
Chang HC, Zhang S, Thieu VT, Slee RB, Bruns HA, Laribee RN, Klemsz MJ, Kaplan MH (2005). PU.1 expression delineates heterogeneity in primary Th2 cells. Immunity 22: 693-703.
Coombes JL, Siddiqui KR, Arancibia-Carcamo CV, Hall J, Sun CM, Belkaid Y, Powrie F (2007). A functionally specialized population of mucosal CD103+ DCs induces Foxp3+ regulatory T cells via a TGF-beta and retinoic acid-dependent mechanism. J Exp Med 204: 1757-1764.
da Cunha AP, Weiner HL (2012). Induction of immunological tolerance by oral anti-CD3. Clin Dev Immunol 2012: 425021.
Das J, Ren G, Zhang L, Roberts AI, Zhao X, Bothwell AL, Van Kaer L, Shi Y, Das G (2009). Transforming growth factor beta is dispensable for the molecular orchestration of Th17 cell differentiation. J Exp Med 206: 2407-2416.
Davidson TS, DiPaolo RJ, Andersson J, Shevach EM (2007). Cutting edge: IL-2 is essential for TGF-beta-mediated induction of Foxp3+ T regulatory cells. J Immunol 178: 4022-4026.
de Jong R, van Lier RA, Ruscetti FW, Schmitt C, Debre P, Mossalayi MD (1994). Differential effect of transforming growth factorbeta 1 on the activation of human naive and memory CD4+ T lymphocytes. Int Immunol 6: 631-638.
Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F (2009). Production of interleukin 22 but not interleukin 17 by a subset of human skin-homing memory T cells. Nat Immunol 10: 857- 863.
Elyaman W, Bassil R, Bradshaw EM, Orent W, Lahoud Y, Zhu B, Radtke F, Yagita H, Khoury SJ (2012). Notch receptors and Smad3 signaling cooperate in the induction of interleukin-9- producing T cells. Immunity 36: 623-634.
Eyerich S, Eyerich K, Pennino D, Carbone T, Nasorri F, Pallotta S, Cianfarani F, Odorisio T, Traidl-Hoffmann C, Behrendt H et al. (2009). Th22 cells represent a distinct human T cell subset involved in epidermal immunity and remodeling. J Clin Invest 119: 3573-3585.
Fahlen L, Read S, Gorelik L, Hurst SD, Coffman RL, Flavell RA, Powrie F (2005). T cells that cannot respond to TGF-beta escape control by CD4+CD25+ regulatory T cells. J Exp Med 201: 737-746.
Floess S, Freyer J, Siewert C, Baron U, Olek S, Polansky J, Schlawe K, Chang HD, Bopp T, Schmitt E et al. (2007). Epigenetic control of the foxp3 locus in regulatory T cells. PLoS Biol 5: e38.
Fontenot JD, Rasmussen JP, Williams LM, Dooley JL, Farr AG, Rudensky AY (2005). Regulatory T cell lineage specification by the forkhead transcription factor foxp3. Immunity 22: 329-341.
Fujita H, Nograles KE, Kikuchi T, Gonzalez J, Carucci JA, Krueger JG (2009). Human Langerhans cells induce distinct IL-22- producing CD4+ T cells lacking IL-17 production. P Natl Acad Sci USA 106: 21795-21800.
Ghoreschi K, Laurence A, Yang XP, Tato CM, McGeachy MJ, Konkel JE, Ramos HL, Wei L, Davidson TS, Bouladoux N et al. (2010). Generation of pathogenic TH17 cells in the absence of TGFbeta signalling. Nature 467: 967-971.
Gorelik L, Fields PE, Flavell RA (2000). Cutting edge: TGF-beta inhibits Th type 2 development through inhibition of GATA-3 expression. J Immunol 165: 4773-4777.
Gorelik L, Flavell RA (2000). Abrogation of TGFβ signaling in T cells leads to spontaneous T cell differentiation and autoimmune disease. Immunity 12: 171-181.
Gu AD, Wang Y, Lin L, Zhang SS, Wan YY (2012). Requirements of transcription factor Smad-dependent and -independent TGFbeta signaling to control discrete T-cell functions. P Natl Acad Sci USA 109: 905-910.
Gu J, Lu L, Chen M, Xu L, Lan Q, Li Q, Liu Z, Chen G, Wang P, Wang X et al. (2014). TGF-β-induced CD4+Foxp3+ T cells attenuate acute graft-versus-host disease by suppressing expansion and killing of effector CD8+ cells. J Immunol 193: 3388-3397.
Guilliams M, Crozat K, Henri S, Tamoutounour S, Grenot P, Devilard E, de Bovis B, Alexopoulou L, Dalod M, Malissen B (2010). Skin-draining lymph nodes contain dermis-derived CD103(- ) dendritic cells that constitutively produce retinoic acid and induce Foxp3+ regulatory T cells. Blood 115: 1958-1968.
Gutcher I, Donkor MK, Ma Q, Rudensky AY, Flavell RA, Li MO (2011). Autocrine transforming growth factor-β1 promotes in vivo Th17 cell differentiation. Immunity 34: 396-408.
Hill JA, Hall JA, Sun CM, Cai Q, Ghyselinck N, Chambon P, Belkaid Y, Mathis D, Benoist C (2008). Retinoic acid enhances Foxp3 induction indirectly by relieving inhibition from CD4+CD44hi cells. Immunity 29: 758-770.
Hori S, Nomura T, Sakaguchi S (2003). Control of regulatory T cell development by the transcription factor Foxp3. Science 299: 1057-1061.
Horwitz DA, Zheng SG, Gray JD, Wang JH, Ohtsuka K, Yamagiwa S (2004). Regulatory T cells generated ex vivo as an approach for the therapy of autoimmune disease. Semin Immunol 16: 135-143.
Ichiyama K, Sekiya T, Inoue N, Tamiya T, Kashiwagi I, Kimura A, Morita R, Muto G, Shichita T, Takahashi R et al. (2011). Transcription factor Smad-independent T helper 17 cell induction by transforming-growth factor-beta is mediated by suppression of eomesodermin. Immunity 34: 741-754.
Jiang R, Tan Z, Deng L, Chen Y, Xia Y, Gao Y, Wang X, Sun B (2011). Interleukin-22 promotes human hepatocellular carcinoma by activation of STAT3. Hepatology 54: 900-909.
Jiang R, Wang H, Deng L, Hou J, Shi R, Yao M, Gao Y, Yao A, Wang X, Yu L et al. (2013). IL-22 is related to development of human colon cancer by activation of STAT3 colorectal cancer survivorship: movement matters. BMC Cancer 13: 1-11.
Josefowicz SZ, Lu LF, Rudensky AY (2012a). Regulatory T cells: mechanisms of differentiation and function. Annu Rev Immunol 30: 531-564.
Josefowicz SZ, Niec RE, Kim HY, Treuting P, Chinen T, Zheng Y, Umetsu DT, Rudensky AY (2012b). Extrathymically generated regulatory T cells control mucosal TH2 inflammation. Nature 482: 395-399.
Kang SG, Lim HW, Andrisani OM, Broxmeyer HE, Kim CH (2007). Vitamin A metabolites induce gut-homing FoxP3+ regulatory T cells. J Immunol 179: 3724-3733.
Kärner J, Wawrzyniak M, Tankov S, Runnel T, Aints A, Kisand K, Altraja A, Kingo K, Akdis CA, Akdis M et al. (2016). Increased microRNA-323-3p in IL-22/IL-17-producing T cells and asthma: a role in the regulation of the TGF-β pathway and IL-22 production. Allergy (in press).
Koenecke C, Czeloth N, Bubke A, Schmitz S, Kissenpfennig A, Malissen B, Huehn J, Ganser A, Förster R, Prinz I (2009). Alloantigenspecific de novo-induced Foxp3+ Treg revert in vivo and do not protect from experimental GVHD. Eur J Immunol 39: 3091-3096.
Kong N, Lan Q, Chen M, Wang J, Shi W, Horwitz DA, Quesniaux V, Ryffel B, Liu Z, Brand D et al. (2012). Antigen-specific transforming growth factor β-induced Treg cells, but not natural Treg cells, ameliorate autoimmune arthritis in mice by shifting the Th17/Treg cell balance from Th17 predominance to Treg cell predominance. Arthritis Rheumatol 64: 2548-2558.
Kretschmer K, Apostolou I, Hawiger D, Khazaie K, Nussenzweig MC, von Boehmer H (2005). Inducing and expanding regulatory T cell populations by foreign antigen. Nat Immunol 6: 1219-1227.
Kronenberg M, Rudensky A (2005). Regulation of immunity by selfreactive T cells. Nature 435: 598-604.
Kuwahara M, Yamashita M, Shinoda K, Tofukuji S, Onodera A, Shinnakasu R, Motohashi S, Hosokawa H, Tumes D, Iwamura C et al. (2012). The transcription factor Sox4 is a downstream target of signaling by the cytokine TGF-beta and suppresses T(H)2 differentiation. Nat Immunol 13: 778-786.
Lan Q, Fan H, Quesniaux V, Ryffel B, Liu Z, Zheng SG (2012). Induced Foxp3+ regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases? J Mol Cell Biol 4: 22-28.
Laurence A, Tato CM, Davidson TS, Kanno Y, Chen Z, Yao Z, Blank RB, Meylan F, Siegel R, Hennighausen L et al. (2007). Interleukin-2 signaling via STAT5 constrains T helper 17 cell generation. Immunity 26: 371-381.
Lee Y, Awasthi A, Yosef N, Quintana FJ, Xiao S, Peters A, Wu C, Kleinewietfeld M, Kunder S, Hafler DA et al. (2012). Induction and molecular signature of pathogenic TH17 cells. Nat Immunol 13: 991-999.
Letterio JJ, Roberts AB (1998). Regulation of immune responses by TGF-beta. Annu Rev Immunol 16: 137-161.
Li MO, Sanjabi S, Flavell RA (2006a). Transforming growth factorbeta controls development, homeostasis, and tolerance of T cells by regulatory T cell-dependent and -independent mechanisms. Immunity 25: 455-471.
Li MO, Wan YY, Flavell RA (2007). T cell-produced transforming growth factor-β1 controls T cell tolerance and regulates Th1- and Th17-cell differentiation. Immunity 26: 579-591.
Li MO, Wan YY, Sanjabi S, Robertson AK, Flavell RA (2006b). Transforming growth factor-beta regulation of immune responses. Annu Rev Immunol 24: 99-146.
Liston A, Rudensky AY (2007). Thymic development and peripheral homeostasis of regulatory T cells. Curr Opin Immunol 19: 176- 185.
Liu Y, Zhang P, Li J, Kulkarni AB, Perruche S, Chen W (2008). A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat Immunol 9: 632-640.
Lu L, Lan Q, Li Z, Zhou X, Gu J, Li Q, Wang J, Chen M, Liu Y, Shen Y et al. (2014). Critical role of all-trans retinoic acid in stabilizing human natural regulatory T cells under inflammatory conditions. P Natl Acad Sci USA 111: E3432-3440.
Lu L, Ma J, Li Z, Lan Q, Chen M, Liu Y, Xia Z, Wang J, Han Y, Shi W et al. (2011). All-trans retinoic acid promotes TGF-β-induced Tregs via histone modification but not DNA demethylation on Foxp3 gene locus. PLoS One 6: e24590.
Lu L, Wang J, Zhang F, Chai Y, Brand D, Wang X, Horwitz DA, Shi W, Zheng SG (2010a). Role of SMAD and non-SMAD signals in the development of Th17 and regulatory T cells. J Immunol 184: 4295-4306.
Lu L, Zhou X, Wang J, Zheng SG, Horwitz DA (2010b). Characterization of protective human CD4CD25 FOXP3 regulatory T cells generated with IL-2, TGF-β and retinoic acid. PLoS One 5: e15150.
Lu LF, Lind EF, Gondek DC, Bennett KA, Gleeson MW, Pino-Lagos K, Scott ZA, Coyle AJ, Reed JL, Van Snick J et al. (2006). Mast cells are essential intermediaries in regulatory T-cell tolerance. Nature 442: 997-1002.
Ludviksson BR, Seegers D, Resnick AS, Strober W (2000). The effect of TGF-β1 on immune responses of naive versus memory CD4+ Th1/Th2 T cells. Eur J Immunol 30: 2101-2111.
Ma J, Liu Y, Li Y, Gu J, Liu J, Tang J, Wang J, Ryffel B, Shen Y, Brand D et al. (2014). Differential role of all-trans retinoic acid in promoting the development of CD4+ and CD8+ regulatory T cells. J Leukoc Biol 95: 275-283.
Makeyev EV, Maniatis T (2008). Multilevel regulation of gene expression by microRNAs. Science 319: 1789-1790.
Mangan PR, Harrington LE, OQuinn DB, Helms WS, Bullard DC, Elson CO, Hatton RD, Wahl SM, Schoeb TR, Weaver CT (2006). Transforming growth factor-beta induces development of the T(H)17 lineage. Nature 441: 231-234.
Marie JC, Letterio JJ, Gavin M, Rudensky AY (2005). TGF-β1 maintains suppressor function and Foxp3 expression in CD4+CD25+ regulatory T cells. J Exp Med 201: 1061-1067.
Marie JC, Liggitt D, Rudensky AY (2006). Cellular mechanisms of fatal early-onset autoimmunity in mice with the T cellspecific targeting of transforming growth factor-beta receptor. Immunity 25: 441-454.
Martinez GJ, Zhang Z, Chung Y, Reynolds JM, Lin X, Jetten AM, Feng XH, Dong C (2009). Smad3 differentially regulates the induction of regulatory and inflammatory T cell differentiation. J Biol Chem 284: 35283-35286.
Mathis D, Benoist C (2004). Back to central tolerance. Immunity 20: 509-516.
Maynard CL, Harrington LE, Janowski KM, Oliver JR, Zindl CL, Rudensky AY, Weaver CT (2007). Regulatory T cells expressing interleukin 10 develop from Foxp3+ and Foxp3- precursor cells in the absence of interleukin 10. Nat Immunol 8: 931-941.
McGeachy MJ, Bak-Jensen KS, Chen Y, Tato CM, Blumenschein W, McClanahan T, Cua DJ (2007). TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat Immunol 8: 1390-1397.
Mu Y, Gudey SK, Landstrom M (2012). Non-Smad signaling pathways. Cell Tissue Res 347: 11-20.
Murphy KM, Reiner SL (2002). The lineage decisions of helper T cells. Nat Rev Immunol 2: 933-944.
Neurath MF, Weigmann B, Finotto S, Glickman J, Nieuwenhuis E, Iijima H, Mizoguchi A, Mizoguchi E, Mudter J, Galle PR et al. (2002). The transcription factor T-bet regulates mucosal T cell activation in experimental colitis and Crohns disease. J Exp Med 195: 1129-1143.
OConnor RA, Floess S, Huehn J, Jones SA, Anderton SM (2012). Foxp3⁺ Treg cells in the inflamed CNS are insensitive to IL-6- driven IL-17 production. Eur J Immunol 42: 1174-1179.
Ouyang W, Beckett O, Ma Q, Li MO (2010). Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity 32: 642- 653.
Peng Y, Laouar Y, Li MO, Green EA, Flavell RA (2004). TGF-beta regulates in vivo expansion of Foxp3-expressing CD4+CD25+ regulatory T cells responsible for protection against diabetes. P Natl Acad Sci USA 101: 4572-4577.
Perumal NB, Kaplan MH (2011). Regulating Il9 transcription in T helper cells. Trends Immunol 32: 146-150.
Piccirillo CA, Letterio JJ, Thornton AM, McHugh RS, Mamura M, Mizuhara H, Shevach EM (2002). CD4+CD25+ regulatory T cells can mediate suppressor function in the absence of transforming growth factor beta1 production and responsiveness. J Exp Med 196: 237-246.
Polansky JK, Kretschmer K, Freyer J, Floess S, Garbe A, Baron U, Olek S, Hamann A, von Boehmer H, Huehn J (2008). DNA methylation controls Foxp3 gene expression. Eur J Immunol 38: 1654-1663.
Ramirez JM, Brembilla NC, Sorg O, Chicheportiche R, Matthes T, Dayer JM, Saurat JH, Roosnek E, Chizzolini C (2010). Activation of the aryl hydrocarbon receptor reveals distinct requirements for IL-22 and IL-17 production by human T helper cells. Eur J Immunol 40: 2450-2459.
Regateiro FS, Howie D, Nolan KF, Agorogiannis EI, Greaves DR, Cobbold SP, Waldmann H (2011). Generation of antiinflammatory adenosine by leukocytes is regulated by TGFbeta. Eur J Immunol 41: 2955-2965.
Romagnani S, Maggi E, Liotta F, Cosmi L, Annunziato F (2009). Properties and origin of human Th17 cells. Mol Immunol 47: 3-7.
Sakaguchi S, Yamaguchi T, Nomura T, Ono M (2008). Regulatory T cells and immune tolerance. Cell 133: 775-787.
Severin ME, Lee PW, Liu Y, Selhorst AJ, Gormley MG, Pei W, Yang Y, Guerau-de-Arellano M, Racke MK, Lovett-Racke AE (2016). MicroRNAs targeting TGFβ signalling underlie the regulatory T cell defect in multiple sclerosis. Brain 139: 1747-1761.
Shull MM, Ormsby I, Kier AB, Pawlowski S, Diebold RJ, Yin M, Allen R, Sidman C, Proetzel G, Calvin D et al. (1992). Targeted disruption of the mouse transforming growth factor-beta 1 gene results in multifocal inflammatory disease. Nature 359: 693-699.
Soroosh P, Doherty TA, Duan W, Mehta AK, Choi H, Adams YF, Mikulski Z, Khorram N, Rosenthal P, Broide DH et al. (2013). Lung-resident tissue macrophages generate Foxp3+ regulatory T cells and promote airway tolerance. J Exp Med 210: 775-788.
Staudt V, Bothur E, Klein M, Lingnau K, Reuter S, Grebe N, Gerlitzki B, Hoffmann M, Ulges A, Taube C et al. (2010). Interferonregulatory factor 4 is essential for the developmental program of T helper 9 cells. Immunity 33: 192-202.
Sun CM, Hall JA, Blank RB, Bouladoux N, Oukka M, Mora JR, Belkaid Y (2007). Small intestine lamina propria dendritic cells promote de novo generation of Foxp3 T reg cells via retinoic acid J Exp Med 204: 1775-1785.
Takaki H, Ichiyama K, Koga K, Chinen T, Takaesu G, Sugiyama Y, Kato S, Yoshimura A, Kobayashi T (2008). STAT6 inhibits TGF-β1-mediated Foxp3 induction through direct binding to the Foxp3 promoter, which is reverted by retinoic acid receptor. J Biol Chem 283: 14955-14962.
Takimoto T, Wakabayashi Y, Sekiya T, Inoue N, Morita R, Ichiyama K, Takahashi R, Asakawa M, Muto G, Mori T et al. (2010). Smad2 and Smad3 are redundantly essential for the TGFbeta-mediated regulation of regulatory T plasticity and Th1 development. J Immunol 185: 842-855.
Tone Y, Furuuchi K, Kojima Y, Tykocinski ML, Greene MI, Tone M (2008). Smad3 and NFAT cooperate to induce Foxp3 expression through its enhancer. Nat Immunol 9: 194-202.
Trifari S, Kaplan CD, Tran EH, Crellin NK, Spits H (2009). Identification of a human helper T cell population that has abundant production of interleukin 22 and is distinct from TH-17, TH1 and TH2 cells. Nat Immunol 10: 864-871.
Tsuji M, Komatsu N, Kawamoto S, Suzuki K, Kanagawa O, Honjo T, Hori S, Fagarasan S (2009). Preferential generation of follicular B helper T cells from Foxp3+ T cells in gut Peyers patches. Science 323: 1488-1492.
van der Vliet HJ, Nieuwenhuis EE (2007). IPEX as a result of mutations in FOXP3. Clin Dev Immunol 2007: 89017.
Veldhoen M, Hocking RJ, Atkins CJ, Locksley RM, Stockinger B (2006). TGFβ in the context of an inflammatory cytokine milieu supports de novo differentiation of IL-17-producing T cells. Immunity 24: 179-189.
Veldhoen M, Uyttenhove C, van Snick J, Helmby H, Westendorf A, Buer J, Martin B, Wilhelm C, Stockinger B (2008). Transforming growth factor-beta reprograms the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9: 1341-1346.
Walker LS, Abbas AK (2002). The enemy within: keeping self-reactive T cells at bay in the periphery. Nat Rev Immunol 2: 11-19.
Wan YY, Flavell RA (2007). Regulatory T-cell functions are subverted and converted owing to attenuated Foxp3 expression. Nature 445: 766-770.
Wolk K, Witte E, Hoffmann U, Doecke WD, Endesfelder S, Asadullah K, Sterry W, Volk HD, Wittig BM, Sabat R (2007). IL-22 induces lipopolysaccharide-binding protein in hepatocytes: a potential systemic role of IL-22 in Crohns disease. J Immunol 178: 5973-5981.
Xiao X, Balasubramanian S, Liu W, Chu X, Wang H, Taparowsky EJ, Fu YX, Choi Y, Walsh MC, Li XC (2012). OX40 signaling favors the induction of T(H)9 cells and airway inflammation. Nat Immunol 13: 981-990.
Xu L, Kitani A, Fuss I, Strober W (2007). Cutting edge: regulatory T cells induce CD4+CD25-Foxp3- T cells or are self-induced to become Th17 cells in the absence of exogenous TGF-beta. J Immunol 178: 6725-6729.
Xu L, Kitani A, Strober W (2010a). Molecular mechanisms regulating TGF-beta-induced Foxp3 expression. Mucosal Immunol 3: 230-238.
Xu L, Kitani A, Stuelten C, McGrady G, Fuss I, Strober W (2010b). Positive and negative transcriptional regulation of the Foxp3 gene is mediated by access and binding of the Smad3 protein to enhancer I. Immunity 33: 313-325.
Zheng SG, Gray JD, Ohtsuka K, Yamagiwa S, Horwitz DA (2002). Generation ex vivo of TGF-beta-producing regulatory T cells from CD4+CD25- precursors. J Immunol 169: 4183-4189.
Zheng SG, Wang J, Horwitz DA (2008a). Cutting edge: Foxp3+CD4+CD25+ regulatory T cells induced by IL-2 and TGF-beta are resistant to Th17 conversion by IL-6. J Immunol 180: 7112-7116.
Zheng SG, Wang J, Wang P, Gray JD, Horwitz DA (2007). IL-2 is essential for TGF-beta to convert naive CD4+CD25- cells to CD25+Foxp3+ regulatory T cells and for expansion of these cells. J Immunol 178: 2018-2027.
Zheng SG, Wang JH, Gray JD, Soucier H, Horwitz DA (2004a). Natural and induced CD4+CD25+ cells educate CD4+CD25- cells to develop suppressive activity: the role of IL-2, TGF-beta, and IL-10. J Immunol 172: 5213-5221.
Zheng SG, Wang JH, Koss MN, Quismorio F, Gray JD, Horwitz DA (2004b). CD4+ and CD8+ regulatory T cells generated ex vivo with IL-2 and TGF-beta suppress a stimulatory graft-versushost disease with a lupus-like syndrome. J Immunol 172: 1531- 1539.
Zheng Y, Josefowicz S, Chaudhry A, Peng XP, Forbush K, Rudensky AY (2010). Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate. Nature 463: 808-812.
Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, Sauvage FJD et al. (2008b). Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282-289.
Zhou L, Lopes JE, Chong MM, Ivanov II, Min R, Victora GD, Shen Y, Du J, Rubtsov YP, Rudensky AY et al. (2008). TGF-β-induced Foxp3 inhibits T(H)17 cell differentiation by antagonizing RORγt function. Nature 453: 236-240.
Zhou X, Kong N, Wang J, Fan H, Zou H, Horwitz D, Brand D, Liu Z, Zheng SG (2010). Cutting edge: all-trans retinoic acid sustains the stability and function of natural regulatory T cells in an inflammatory milieu. J Immunol 185: 2675-2679.
Zhu J, Davidson TS, Wei G, Jankovic D, Cui K, Schones DE, Guo L, Zhao K, Shevach EM, Paul WE (2009). Down-regulation of Gfi-1 expression by TGF-beta is important for differentiation of Th17 and CD103+ inducible regulatory T cells. J Exp Med 206: 329-341.